// App-Quantinova.ai

Su1437 : INTRA-SPHINCTERIC BOTULINUM TOXIN INJECTION IN THE MANAGEMENT OF TYPE III SPHINCTER OF ODDI DYSFUNCTION: IS IT EFFECTIVE?

Researchers

Presenter

  • Shyam Menon

Principal Investigators

  • Adam D. Farmer

  • Andrew Holt

Medical Centers

  • University Hospital of North Midlands, Stoke-on-Trent, United Kingdom

  • The Royal Wolverhampton NHS Trust,Wolverhampton, UK

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Superoxide dismutase

Drug/Treatment

  • Botulinum toxin A

  • Epimorph

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved